A detailed history of Amalgamated Bank transactions in Orasure Technologies Inc stock. As of the latest transaction made, Amalgamated Bank holds 2,463 shares of OSUR stock, worth $8,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,463
Previous 2,463 -0.0%
Holding current value
$8,916
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.2 - $6.18 $89,233 - $131,300
-21,246 Reduced 89.61%
2,463 $10,000
Q1 2024

Apr 23, 2024

SELL
$6.08 - $8.28 $24,551 - $33,434
-4,038 Reduced 14.55%
23,709 $146,000
Q4 2023

Feb 06, 2024

SELL
$5.13 - $8.35 $8,710 - $14,178
-1,698 Reduced 5.77%
27,747 $228,000
Q2 2023

Aug 11, 2023

SELL
$4.88 - $7.39 $3,889 - $5,889
-797 Reduced 2.64%
29,445 $147,000
Q1 2023

May 02, 2023

SELL
$4.66 - $6.52 $11,626 - $16,267
-2,495 Reduced 7.62%
30,242 $183,000
Q3 2022

Nov 09, 2022

SELL
$2.72 - $4.61 $712 - $1,207
-262 Reduced 0.79%
32,737 $124,000
Q2 2022

Aug 15, 2022

BUY
$2.71 - $7.12 $2,663 - $6,998
983 Added 3.07%
32,999 $89,000
Q1 2022

Jun 30, 2022

SELL
$6.62 - $9.33 $12,750 - $17,969
-1,926 Reduced 5.67%
32,016 $217,000
Q4 2021

Feb 15, 2022

SELL
$8.3 - $11.29 $8,258 - $11,233
-995 Reduced 2.85%
33,942 $295,000
Q3 2021

Oct 29, 2021

SELL
$9.73 - $13.38 $5,380 - $7,399
-553 Reduced 1.56%
34,937 $395,000
Q2 2021

Aug 16, 2021

BUY
$9.02 - $11.68 $320,119 - $414,523
35,490 New
35,490 $360,000
Q1 2020

May 13, 2020

SELL
$5.57 - $10.76 $58,145 - $112,323
-10,439 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$7.21 - $8.89 $75,265 - $92,802
10,439 New
10,439 $84,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $263M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.